Below is the collection of news reports, blog posts, and opinion pieces collected for today related to Down syndrome and prenatal testing. The stories today seemed to have a theme more than other days. Continue Reading
What to expect for Down syndrome prenatal testing for 2014
This week's posts so far have shared the top 5 blog posts from the past and the top developments in Down syndrome prenatal testing in 2013. With the new year just beginning, we now look ahead to what can be expected for Down syndrome prenatal testing in 2014. Continue Reading
Top developments in Down syndrome prenatal testing for 2013
Finishing the year-in-review posts, here are what I believe are the developments in Down syndrome prenatal testing that had and will have the greatest impact from 2013: Continue Reading
“Any/Particular” critique of disability selective abortion: remembering Adrienne Asch
Over the weekend, an important voice in the discussion of the ethics of prenatal testing for disability fell silent. Adrienne Asch made critical contributions from a seemingly conflicted position: vigorously pro-choice but condemning of selective abortion for disability. Continue Reading
Sweden: more Down syndrome prenatal testing, more selective abortion
That is the news out of Sweden: as prenatal testing for Down syndrome has expanded, there have been more abortions following a Down syndrome diagnosis. What do you think about the way this news was reported? Continue Reading
Where the DoD/VA prenatal testing guidelines fall short: the need for post-test counseling
With Veterans Day starting off this week, I have been examining the Department of Defense/Veterans Administrations guidelines concerning prenatal genetic testing. So far, the guidelines provide the most robust recommendations for pre-test counseling. Here, however, is where the guidelines fall short. Continue Reading
Not a termination rate. An elimination rate.
If you haven't noticed, a while back I added a "News" page to the blog (you can find the link under the tab for "Articles" on the homepage). Here's a news item where a 90% termination rate would actually be lower than what is happening. Continue Reading
Why is “being ahead of the curve” a selling point for Verinata’s verifi?
Thursday, Non-Invasive Prenatal Screening (NIPS) laboratory Verinata is hosting a webinar open to the public about its brand of testing, verifi. Verinata's choice in marketing taglines raises serious ethical concerns. Continue Reading
Emily Oster’s Expecting Better: Voldemort’s Shadow
In Expecting Better, Economics Professor Emily Oster bucks the conventional wisdom of standard prenatal care. Her book's title, and her support for early prenatal genetic testing, however, casts an ominous, unspoken shadow. Continue Reading
Recent Comments